Ingevity Balance Sheet Health

Financial Health criteria checks 1/6

Ingevity has a total shareholder equity of $631.4M and total debt of $1.4B, which brings its debt-to-equity ratio to 216.4%. Its total assets and total liabilities are $2.6B and $2.0B respectively. Ingevity's EBIT is $256.1M making its interest coverage ratio 2.9. It has cash and short-term investments of $95.9M.

Key information

216.4%

Debt to equity ratio

US$1.37b

Debt

Interest coverage ratio2.9x
CashUS$95.90m
EquityUS$631.40m
Total liabilitiesUS$1.99b
Total assetsUS$2.62b

Recent financial health updates

Recent updates

Are Investors Undervaluing Ingevity Corporation (NYSE:NGVT) By 44%?

Apr 18
Are Investors Undervaluing Ingevity Corporation (NYSE:NGVT) By 44%?

Is Ingevity (NYSE:NGVT) A Risky Investment?

Mar 22
Is Ingevity (NYSE:NGVT) A Risky Investment?

What Is Ingevity Corporation's (NYSE:NGVT) Share Price Doing?

Jan 23
What Is Ingevity Corporation's (NYSE:NGVT) Share Price Doing?

Ingevity Corporation (NYSE:NGVT) Doing What It Can To Lift Shares

Jan 04
Ingevity Corporation (NYSE:NGVT) Doing What It Can To Lift Shares

These Analysts Just Made An Incredible Downgrade To Their Ingevity Corporation (NYSE:NGVT) EPS Forecasts

Nov 10
These Analysts Just Made An Incredible Downgrade To Their Ingevity Corporation (NYSE:NGVT) EPS Forecasts

Is It Time To Consider Buying Ingevity Corporation (NYSE:NGVT)?

Oct 07
Is It Time To Consider Buying Ingevity Corporation (NYSE:NGVT)?

Ingevity Corporation: The Risk To Reward Is Currently Favorable

Oct 06

Ingevity (NYSE:NGVT) Takes On Some Risk With Its Use Of Debt

Sep 22
Ingevity (NYSE:NGVT) Takes On Some Risk With Its Use Of Debt

Is There An Opportunity With Ingevity Corporation's (NYSE:NGVT) 31% Undervaluation?

Aug 11
Is There An Opportunity With Ingevity Corporation's (NYSE:NGVT) 31% Undervaluation?

Ingevity Corporation: Headwinds Are Temporary

Jul 05

Ingevity (NYSE:NGVT) Takes On Some Risk With Its Use Of Debt

Jun 21
Ingevity (NYSE:NGVT) Takes On Some Risk With Its Use Of Debt

Is There Now An Opportunity In Ingevity Corporation (NYSE:NGVT)?

May 29
Is There Now An Opportunity In Ingevity Corporation (NYSE:NGVT)?

We Think Ingevity (NYSE:NGVT) Can Stay On Top Of Its Debt

Feb 16
We Think Ingevity (NYSE:NGVT) Can Stay On Top Of Its Debt

Is Ingevity Corporation (NYSE:NGVT) Potentially Undervalued?

Jan 25
Is Ingevity Corporation (NYSE:NGVT) Potentially Undervalued?

Ingevity Corporation (NYSE:NGVT) Shares Could Be 39% Below Their Intrinsic Value Estimate

Sep 13
Ingevity Corporation (NYSE:NGVT) Shares Could Be 39% Below Their Intrinsic Value Estimate

Is It Time To Consider Buying Ingevity Corporation (NYSE:NGVT)?

Aug 22
Is It Time To Consider Buying Ingevity Corporation (NYSE:NGVT)?

Ingevity to acquire pavement marking materials business Ozark Materials for $325M

Aug 02

Ingevity (NYSE:NGVT) Seems To Use Debt Quite Sensibly

Aug 01
Ingevity (NYSE:NGVT) Seems To Use Debt Quite Sensibly

Ingevity (NYSE:NGVT) Will Want To Turn Around Its Return Trends

Jun 05
Ingevity (NYSE:NGVT) Will Want To Turn Around Its Return Trends

What Does Ingevity Corporation's (NYSE:NGVT) Share Price Indicate?

May 20
What Does Ingevity Corporation's (NYSE:NGVT) Share Price Indicate?

Ingevity: Well-Diversified ESG Chemicals Company To Put On Watchlist

May 03

We Think Ingevity (NYSE:NGVT) Can Stay On Top Of Its Debt

May 02
We Think Ingevity (NYSE:NGVT) Can Stay On Top Of Its Debt

Investors Could Be Concerned With Ingevity's (NYSE:NGVT) Returns On Capital

Mar 03
Investors Could Be Concerned With Ingevity's (NYSE:NGVT) Returns On Capital

We Think Ingevity (NYSE:NGVT) Can Stay On Top Of Its Debt

Jan 19
We Think Ingevity (NYSE:NGVT) Can Stay On Top Of Its Debt

Are Investors Undervaluing Ingevity Corporation (NYSE:NGVT) By 42%?

Dec 06
Are Investors Undervaluing Ingevity Corporation (NYSE:NGVT) By 42%?

Be Wary Of Ingevity (NYSE:NGVT) And Its Returns On Capital

Nov 18
Be Wary Of Ingevity (NYSE:NGVT) And Its Returns On Capital

Is Ingevity (NYSE:NGVT) A Risky Investment?

Oct 04
Is Ingevity (NYSE:NGVT) A Risky Investment?

An Intrinsic Calculation For Ingevity Corporation (NYSE:NGVT) Suggests It's 38% Undervalued

Sep 04
An Intrinsic Calculation For Ingevity Corporation (NYSE:NGVT) Suggests It's 38% Undervalued

Investors Met With Slowing Returns on Capital At Ingevity (NYSE:NGVT)

Aug 20
Investors Met With Slowing Returns on Capital At Ingevity (NYSE:NGVT)

If You Like EPS Growth Then Check Out Ingevity (NYSE:NGVT) Before It's Too Late

Aug 05
If You Like EPS Growth Then Check Out Ingevity (NYSE:NGVT) Before It's Too Late

Ingevity (NYSE:NGVT) Has A Pretty Healthy Balance Sheet

Jun 28
Ingevity (NYSE:NGVT) Has A Pretty Healthy Balance Sheet

Is There An Opportunity With Ingevity Corporation's (NYSE:NGVT) 25% Undervaluation?

May 22
Is There An Opportunity With Ingevity Corporation's (NYSE:NGVT) 25% Undervaluation?

Investors Could Be Concerned With Ingevity's (NYSE:NGVT) Returns On Capital

May 04
Investors Could Be Concerned With Ingevity's (NYSE:NGVT) Returns On Capital

Ingevity Corporation 2021 Q1 - Results - Earnings Call Presentation

Apr 30

Financial Position Analysis

Short Term Liabilities: NGVT's short term assets ($658.6M) exceed its short term liabilities ($362.9M).

Long Term Liabilities: NGVT's short term assets ($658.6M) do not cover its long term liabilities ($1.6B).


Debt to Equity History and Analysis

Debt Level: NGVT's net debt to equity ratio (201.2%) is considered high.

Reducing Debt: NGVT's debt to equity ratio has increased from 198.5% to 216.4% over the past 5 years.

Debt Coverage: NGVT's debt is not well covered by operating cash flow (15%).

Interest Coverage: NGVT's interest payments on its debt are not well covered by EBIT (2.9x coverage).


Balance Sheet


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.